Rivian, JD.com, Plus Therapeutics, Bed Bath & Beyond [Reuters]
PLUS THERAPEUTICS, Inc. (PSTV)
Company Research
Source: Reuters
The Morning News Call newsletter: Wall Street's main indexes fell in choppy trading on Thursday after minutes from the Federal Reserve's last meeting struck a hawkish note, pushing down shares of big technology companies and buoying economy-sensitive cyclical sectors. At 10:51 ET, the Dow Jones Industrial Average (.DJI) was down 0.22% at 36,327.9. The S&P 500 (.SPX) was up 0.03% at 4,701.87 and the Nasdaq Composite (.IXIC) was up 0.14% at 15,121.725. BUZZ-Wells Fargo names CrowdStrike top pick for 2022, rates 'overweight' BUZZ-Netflix slips after JP Morgan cuts PT, subscriber estimates BUZZ-Alterity jumps on U.S. patent for compounds targeting brain disorders BUZZ-Freeline Therapeutics soars as FDA clears new drug application BUZZ-Rivian hits record low after Amazon signs deal with Stellantis BUZZ-Plus Therapeutics rises after signing licensing deal for cancer therapy ** Western Union Co (WU.N) : down 2.2% BUZZ-Western Union slips as BofA downgrades on structural,
Show less
Read more
Impact Snapshot
Event Time:
PSTV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PSTV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PSTV alerts
High impacting PLUS THERAPEUTICS, Inc. news events
Weekly update
A roundup of the hottest topics
PSTV
News
- Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management TeamGlobeNewswire
- Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual ConferenceGlobeNewswire
- Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic [Yahoo! Finance]Yahoo! Finance
- Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell DiagnosticGlobeNewswire
- Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases [Yahoo! Finance]Yahoo! Finance
PSTV
Earnings
- 10/31/23 - Miss
PSTV
Sec Filings
- 3/14/24 - Form 8-K
- 3/13/24 - Form 8-K
- 3/8/24 - Form S-1/A
- PSTV's page on the SEC website